<DOC>
	<DOCNO>NCT01837615</DOCNO>
	<brief_summary>Low Level Light therapy ( LLLT ) use tissue heal many mucosal disease involve wound , ulcer inflammation , oral chemotherapy-induced mucositis particular . Likewise IBD characterize chronic tissue inflammation , tissue damage ulceration various extent . Therefore hypothesize LLLT might effective treat IBD Photopill capsule develop purpose . An open-label , interventional , clinical trial design assessment safety feasibilty Photopill capsule treatment patient mild moderate Ulcerative Proctitis . Primary endpoint : safety reflect number severity adverse event mucosal appearance sigmoidoscopy day 14 , day 28 , day 42 compare baseline condition . Furthermore clinical biochemical parameter monitor study .</brief_summary>
	<brief_title>Assessment Photopill Capsule Treatment Safety Feasibility Ulcerative Proctitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Proctitis</mesh_term>
	<criteria>Diagnosed Ulcerative Proctitis ( Mayo grade 1/2 ) Symptomatic hemorrhoid Pregnant lactating female Patients use experimental treatment within 8 week prior Day 0 Patient use biologics therapy immunomodulation agent and/or steroid 4 week prior Day 0 Rectal therapy 2 week prior Day 0</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Ulcerative Proctitis</keyword>
	<keyword>Low Level Light Therapy</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>